Invesco
CAMP icon

Invesco’s CAMP4 Therapeutics CAMP Stock Holding History

Invesco’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98K Buy
+22,425
New +$96.7K ﹤0.01% 3737

Other funds holding CAMP

JT
Jupiter Topco New York $245B AUM
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco's CAMP Position: Q2 2026 in Review

Invesco opened a new position in CAMP4 Therapeutics (CAMP) in Q2 2026: 22,425 shares worth $98K. The stake represents ﹤0.01% of the portfolio and ranks #3737 among its holdings.

61 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Invesco held 22,425 shares of CAMP4 Therapeutics worth $98K as of Q2 2026.
  • CAMP4 Therapeutics was a new Invesco position in Q2 2026.
  • CAMP4 Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3737 holding.
  • 61 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.